Table 1.
Groups | n | 24 h post-transfection | 48 h post-transfection | 72 h post-transfection | |||
---|---|---|---|---|---|---|---|
| |||||||
HBsAg (ng/ml) | HBeAg (PEIU/ml) | HBsAg (ng/ml) | HBeAg (PEIU/ml) | HBsAg (ng/ml) | HBeAg (PEIU/ml) | ||
Blank control | 5 | 0.10±0.02 | 0.21±0.02 | 0.11±0.02 | 0.15±0.02 | 0.12±0.02 | 0.17±0.03 |
Vector control | 5 | 0.10±0.01 | 0.14±0.02 | 0.16±0.02 | 0.19±0.03 | 0.10±0.02 | 0.21±0.03 |
HBV transfection | 5 | 0.16±0.02 | 0.12±0.02 | 0.51±0.03* | 1.02±0.04* | 2.62±0.02* | 1.93±0.06* |
Inhibitor treatment | 5 | 0.10±0.03 | 0.20±0.01 | 0.13±0.02 | 0.17±0.02 | 0.11±0.02 | 0.18±0.03 |
Note: Compared with the control groups,
P < 0.05.
HBsAg and HBeAg quantification > 1.0 was considered as positive, while < 1.0 was considered as negative.